{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:48:13Z","timestamp":1780084093434,"version":"3.54.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0857-7","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T01:40:26Z","timestamp":1492566026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Clinical predictors for the prognosis of myasthenia gravis"],"prefix":"10.1186","volume":"17","author":[{"given":"Lili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"857_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","volume":"273","author":"YH Hong","year":"2008","unstructured":"Hong YH, Kwon SB, Kim BJ, Kim BJ, Kim SH, Kim JK, et al. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients. J Neurol Sci. 2008;273:10\u20134.","journal-title":"J Neurol Sci"},{"key":"857_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/mus.21555","volume":"41","author":"JA Allen","year":"2010","unstructured":"Allen JA, Scala S, Jones HR. Ocular myasthenia gravis in senior population: diagnosis, therapy, and prognosis. Muscle Nerve. 2010;41:379\u201384.","journal-title":"Muscle Nerve"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneur.60.10.1491-b","volume":"60","author":"TH Papapetropoulous","year":"2003","unstructured":"Papapetropoulous TH, Ellul J, Tsibri E. Development of generalized myasthenia gravis in patients with ocular myasthenia. Arch Neurol. 2003;60:1491\u20132.","journal-title":"Arch Neurol"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00041327-200312000-00002","volume":"23","author":"J Mee","year":"2003","unstructured":"Mee J, Paine M, Byrne E, King J, Reardon K, O'Day J. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis. J Neuro opthalmol. 2003;23:251\u20135.","journal-title":"J Neuro opthalmol"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archneur.60.2.243","volume":"60","author":"MJ Kupersmith","year":"2003","unstructured":"Kupersmith MJ, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol. 2003;60:243\u20138.","journal-title":"Arch Neurol"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","volume":"217","author":"NT Monsul","year":"2004","unstructured":"Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. J Neurol Sci. 2004;217:131\u20133.","journal-title":"J Neurol Sci"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0303-8467(02)00104-X","volume":"105","author":"N Wakata","year":"2003","unstructured":"Wakata N, Iguchi H, Sugimoto H, Nomoto N, Kurihara T. Relapse of ocular symptoms after remission of myasthenia gravis-a comparison of relapsed and complete remission cases. Clin Neurol Neurosurg. 2003;105:75\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.03.001","volume":"258","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Nishimoto T, Kohno M, Utsugisawa K, Nagane Y, Kuwana M, Suzuki N. Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis. J Neuroimmunol. 2013;258:61\u20136.","journal-title":"J Neuroimmunol"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03017.x","volume":"17","author":"ZF Mao","year":"2010","unstructured":"Mao ZF, Mo XA, Qin C, Lai YR, Olde Hartman TC. Course and prognosis of myasthenia gravis: a systematic review. Eur J Neurol. 2010;17:913\u201321.","journal-title":"Eur J Neurol"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cei.12217","volume":"175","author":"JP Sieb","year":"2014","unstructured":"Sieb JP. Myasthenia gravis. An update for the clinician. Clin Exp Immunol. 2014;175:408\u201318.","journal-title":"Clin Exp Immunol"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1510\/icvts.2005.116616","volume":"5","author":"HS Hsu","year":"2006","unstructured":"Hsu HS, Huang CS, Huang BS, Lee HC, Kao KP, Hsu WH, et al. Thymoma is associated with relapse of symptoms after transsternal thymectomy for myasthenia gravis. Interact Cardiovasc Thorac Surg. 2006;5:42\u20136.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"857_CR12","first-page":"1446","volume":"88","author":"LN Men","year":"2008","unstructured":"Men LN, Liu WB, Chen ZG, He XT, Zhang Y, Huang R. Prognostic factors related to recurrence after extended thymectomy in patients with myasthenia gravis. Chin J Neurol. 2008;88:1446\u20139.","journal-title":"Chin J Neurol"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki 3rd A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the Medical scientific advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55:16\u201323.","journal-title":"Neurology"},{"key":"857_CR14","first-page":"107","volume":"17","author":"HY Yu","year":"2010","unstructured":"Yu HY, Sun ZW, Qin B, Gong T, Zeng XY, Sun YC. Predictors and influencing factors on prognosis of ocular myasthenia gravis. Chin J Neuroimmunol& Neuro. 2010;17:107\u20139.","journal-title":"Chin J Neuroimmunol& Neuro"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1084\/jem.20141132","volume":"211","author":"A Nakai","year":"2014","unstructured":"Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K. Control of lymphocyte egress from lymph nodes through \u03b22-adrenergic receptors. J Exp Med. 2014;211:2583\u201398.","journal-title":"J Exp Med"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/eji.201243005","volume":"43","author":"MG Guereschi","year":"2013","unstructured":"Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, et al. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol. 2013;43:1001\u201312.","journal-title":"Eur J Immunol"},{"key":"857_CR17","first-page":"828","volume":"42","author":"LL Wang","year":"2009","unstructured":"Wang LL, Xie YC, Hou SF, Feng K, Yin J, Xu XH. Role of \u03b22-adrenergic receptor polymorphisms in pathogenesis of myasthenia gravis. Chin J Neurol. 2009;42:828\u201332.","journal-title":"Chin J Neurol"},{"key":"857_CR18","unstructured":"Wang LL, Zhang Y, He ML. Role of \u03b22-adrenergic receptor polymorphisms in prognosis of myasthenia gravis with other autoimmune diseases. Chin J Neurol. 2015; 48:390\u20134."},{"key":"857_CR19","first-page":"873","volume":"14","author":"LL Wang","year":"2014","unstructured":"Wang LL, Zhang Y, He ML. Clinical characteristics of patients with myasthenia gravis associated with other autoimmune diseases. Chin J Contemp Neurol Neurosurg. 2014;14:873\u20137.","journal-title":"Chin J Contemp Neurol Neurosurg"},{"key":"857_CR20","unstructured":"Wang LL, Zhang Y, He ML. Study of the association of \u03b22-adrenergic receptor gene polymorphism with myasthenia gravis associated with thymus abnormality. Natl Med J China 2015; 95:1518\u201321."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0857-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T01:40:54Z","timestamp":1492566054000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0857-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0857-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]},"article-number":"77"}}